NDC 60687-874 – Guaifenesin
Guaifenesin 300 mg/15mL · Solution · Oral
Product NDC60687-874
Product details
- Brand name
- Guaifenesin
- Generic name
- Guaifenesin
- Labeler
- American Health Packaging
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M012
- Marketed since
- October 20, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Expectorant
Active ingredients
- Guaifenesin 300 mg/15mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 60687-874-16 | 10 TRAY in 1 CASE (60687-874-16) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-874-50) / 15 mL in 1 CUP, UNIT-DOSE (60687-874-44) | Oct 20, 2024 |
Other Guaifenesin products
- 60687-852 Guaifenesin 100 mg/5mL · Solution · American Health Packaging
- 60687-863 Guaifenesin 200 mg/10mL · Solution · American Health Packaging
- 55154-5780 Guaifenesin 200 mg/10mL · Solution · Cardinal Health 107, LLC
- 55154-9450 Guaifenesin 100 mg/5mL · Solution · Cardinal Health 107, LLC
- 0121-0744 Guaifenesin 100 mg/5mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 0121-1488 Guaifenesin 200 mg/10mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 0121-1744 Guaifenesin 100 mg/5mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 0121-2232 Guaifenesin 300 mg/15mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 80513-413 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Advanced Rx LLC
- 46122-750 Guaifenesin 600 mg/1 · Tablet, Extended Release · AMERISOURCE BERGEN
- 65162-036 Guaifenesin 600 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 65162-037 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC